Sign in Subscribe
Genes

Discovery of Prognostic Biomarkers for Colon Cancer May Aid Treatment Decisions

Strategic Insights

— 2 min read

Researchers from Wenzhou Medical University in Zhejiang, People's Republic of China, have identified seven genes associated with antibody-dependent cellular phagocytosis (ADCP) that may serve as prognostic biomarkers for colon cancer. The study, published in Clinical Proteomics, used gene expression profiles and clinical data from the Cancer Genome Atlas (TCGA) database to develop a predictive model that accurately forecasted prognosis for CRC patients. The analysis also revealed that cells with higher scores were mainly concentrated in B cells and macrophages, and that Th1 cells, iDCs, and Th2 cells had higher abundance in the low-ADCPRS group.

Key Takeaways:

  • Researchers have identified 7 ADCP-related genes that may serve as prognostic biomarkers for colon cancer, guiding treatment decisions for CRC patients.
  • The study used gene expression profiles and clinical data from the TCGA database to develop a predictive model that accurately forecasted prognosis for CRC patients.
  • Cells with higher scores were mainly concentrated in B cells and macrophages, and Th1 cells, iDCs, and Th2 cells had higher abundance in the low-ADCPRS group.
  • Functional enrichment analysis revealed that upregulated DEGs in the high-ADCPRS group were mainly enriched in signaling pathways such as the Drug metabolism cytochrome P450, Neuroactive ligand-receptor interaction, and Calcium signaling pathway.
  • Immune infiltration analysis showed that Th1 cells, iDCs, and Th2 cells had higher abundance in the low-ADCPRS group.
  • Gene mutation analysis uncovered that both high- and low-ADCPRS groups had high mutation rates, with APC and TP53 being the top two genes with the highest mutation rates.
  • Drug sensitivity analysis and molecular docking revealed that Dasatinib, Benzaldehyde, and Tegafur may aid in treating CRC patients.
  • The prognostic model developed in this project may function as a potential tool for risk assessment in CRC patients.

Statistics:

  • 7 ADCP-related genes were identified as potential prognostic biomarkers for colon cancer.
  • The predictive model developed in this project accurately forecasted prognosis for CRC patients based on gene expression profiles and clinical data from the TCGA database.
  • 8 cell clusters were examined across the scRNA-seq data analysis, with the 7 feature genes expressed across 3 of these clusters.
  • The high-ADCPRS group had 50 DEGs upregulated, while the low-ADCPRS group had 25 DEGs upregulated.
  • Both the high- and low-ADCPRS groups had high mutation rates, with APC and TP53 being the top two genes with the highest mutation rates.
  • The prognostic model developed in this project was based on the TCGA training set.

Sources:

  • Clinical Proteomics: Revelation of prognosis and tumor microenvironment of colorectal cancer based on genes related to antibody-dependent cellular phagocytosis and single-cell landscape. 2025;22(1):28.
  • Cancer Weekly: Reports Summarize Colon Cancer Findings from Wenzhou Medical University (Revelation of prognosis and tumor microenvironment of colorectal cancer based on genes related to antibody-dependent cellular phagocytosis and single-cell landscape). September 16, 2025; p 464.

Read more